To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.

Association Fransaise Contre l’amylose


66 rue Saint Jacques
13796 Aix en Provence cedex 3
13006 Marseille France




Email Address

[email protected]


The Association Fransaise Contre l'amylose (AFCI) is a voluntary, non-profit, self-help organization that was established in 1994 in France in memory of Paulette, who was affected by a hereditary form of amyloidosis. Amyloidosis is a chronic disorder in which an abnormal starch-like protein complex (amyloid) accumulates in certain tissues and organs of the body. Amyloidosis may occur as a primary disorder for unknown reasons (idiopathic) or may occur secondary to other underlying disorders such as rheumatoid arthritis, familial Mediterranean fever, cancer of the bone marrow (i.e., multiple myeloma), or tuberculosis. In addition, some forms of amyloidosis may be inherited. The specific symptoms and findings vary greatly in range and severity, depending upon which areas of the body are affected. The association is dedicated to promoting and supporting medical research in the fight against amyloidosis; furthering the knowledge of affected individuals, family members, and healthcare professionals; working in association with other related organizations; and providing networking opportunities to individuals with amyloidosis and family members. It also provides appropriate referrals to genetic counseling and engages in patient advocacy.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.